Merck To Support Zocor Into 2006 Based On Strong Formulary Position
This article was originally published in The Pink Sheet Daily
Executive Summary
Position of Zocor, Vytorin on Express Scripts' preferred formulary is a win-win for Merck, CEO Clark states during Q3 call.